Bone Marrow Transplant in Oncology - PowerPoint PPT Presentation

About This Presentation
Title:

Bone Marrow Transplant in Oncology

Description:

Bone Marrow Transplant in Oncology Source Pathology Treat Leukemia by chemotherapy Regeneration of normal marrow Chemotherapy alone cannot eliminate all malignant ... – PowerPoint PPT presentation

Number of Views:343
Avg rating:3.0/5.0
Slides: 21
Provided by: vlo9
Category:

less

Transcript and Presenter's Notes

Title: Bone Marrow Transplant in Oncology


1
Bone Marrow Transplant in Oncology
2
Source
3
Pathology
  • Treat Leukemia by chemotherapy
  • Regeneration of normal marrow
  • Chemotherapy alone cannot eliminate all malignant
    cells
  • Stem cell transplants.

4
Tranplant
  • Patient's bone marrow stem cells are replaced
    with healthy cells
  • Existing bone marrow and abnormal leukocytes
    killed
  • Chemotherapy and radiation
  • Next bone marrow containing healthy stem cells
    re-infused

5
Adult Stem Cell Transplant
6
Procedure
  • Most blood stem cells reside in the bone marrow
    and a small number are present in the bloodstream
  • Multipotent peripheral blood stem cells
  • Can be obtained from drawn blood
  • PBSCs are easier to collect than bone marrow stem
    cells

7
Harvesting
8
Transplantation
  •   Autologous
  •   Allogeneic
  • Syngeneic

9
Indications
  • Hematological diseases
  • Benign Thallassaemia, Aplastic Anaemia
  • Malignant Leukemia Lymphoma Myeloma
  • Immune deficiency disorders
  • Pediatric and Adult
  • Neurological Disease (MS)

10
Auto Transplant
11
Allotransplant

12
(No Transcript)
13
(No Transcript)
14
(No Transcript)
15
(No Transcript)
16
(No Transcript)
17
(No Transcript)
18
Who can be the donorBone marrow donors can be
any normal person who is willing to donate.
Even the comatose patient can be donor.Donor
can not be the cadaver. Preferable if siblings
or parents can donate. This is done just prior
to time of transplant
19
Graft Verses Host Disease (GVHD)
  • GVHD sometimes occurs with allogeneic
    transplantation.
  • Lymphocytes from the donor graft attack the cells
    of the host
  • GVHD can usually be treated with steroids or
    other immunosuppressive agents.
  • Acute GVHD occurs before day 100 post-transplant
  • Chronic GVHD occurs beyond day 100
  • Recent advances have reduced the incidence and
    severity of this post-transplant complication,
    but GVHD, directly or indirectly, still accounts
    for approximately 15 of deaths in stem cell
    transplant patients
  • Chronic GVHD can develop months or even years
    post-transplant

20
GVHD
  • Skin/Hair
  • Rash, scleroderma, lichenoid skin changes,
    dyspigmentation,alopecia
  • Eyes
  • Dryness, abnormal Schirmer's Test,
    cornealerosions, conjunctivitis 
  • Mouth Atrophic changes, lichenoid changes,
    mucositis,ulcers, xerostomia, dental caries
  • Lungs
  • Bronchiolitis obliterans
  • GI tract
  • Esophageal involvement, chronic
    nausea/vomiting, chronic diarrhea, malabsorption,
    fibrosis, abdomina l pain/cramps
  • Liver
  • Abnormal LFTs, biopsy abnormalities
  • Genitourinary
  • Vaginitis, strictures, stenosis, cystitis
  • Musculoskeletal
  • Arthritis, contractures, myositis,
    myasthenia, fascities
  • Hematologic
  • Thrombocytopenia, eosinophilia,
    autoantibodies
Write a Comment
User Comments (0)
About PowerShow.com